logo

For the Inventor, By the Inventor

Sisters, OR, United States of America

Matthew David Wessel

This inventor holds 7 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Nimbus Iris, Inc., Other. Active years: 2008-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew David Wessel. Retrieved from https://idiyas.com/inventor/matthew-david-wessel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 14.3

 

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 51(Granted Patents)


Location History:

  • Groton, CT (US) (2008)
  • Sisters, OR (US) (2014 - 2017)

Company Filing History:

goldMedal6 out of 10 
 
Nimbus Iris, Inc.
 patents
silverMedal1 out of 834,570 
Other
 patents

Years Active: 2008-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 9790234 - IRAK inhibitors and uses thereof (2017-10-17),
2. 9481687 - IRAK inhibitors and uses thereof (2016-11-01),
3. 9340554 - IRAK inhibitors and uses thereof (2016-05-17),
4. 9212190 - IRAK inhibitors and uses thereof (2015-12-15),
5. 9085586 - IRAK inhibitors and uses thereof (2015-07-21),
6. 8703941 - IRAK inhibitors and uses thereof (2014-04-22),
7. 7435739 - Substituted pyrrolopyrimidines useful in the treatment of cancer (2008-10-14),

Certainly! Here is an article about inventor Matthew David Wessel:

Title: Unveiling the Innovations of Matthew David Wessel from Sisters, OR

Introduction:

Matthew David Wessel, a prolific inventor based in Sisters, Oregon, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With a total of 6 patents to his name, Wessel is recognized for his innovative approach to developing cutting-edge solutions in the healthcare industry.

Latest Patents:

Wessel's latest patents revolve around "IRAK inhibitors and uses thereof." These inventions provide arylo-fused thienopyrimidine compounds, along with compositions and methods for their utilization. Wessel's dedication to advancing pharmaceutical research is evident in the impactful nature of these patents.

Career Highlights:

Currently, Matthew David Wessel is an integral part of Nimbus Iris, Inc., a renowned pharmaceutical company known for its commitment to innovation and excellence in drug discovery. Wessel's role at Nimbus Iris, Inc. highlights his expertise and leadership in driving forward-thinking research initiatives.

Collaborations:

Throughout his career, Wessel has collaborated with esteemed professionals in the field. Some of his notable coworkers include Donna Lee Romero and Shaughnessy Robinson, who have collectively contributed to the success of various projects under Wessel's mentorship.

Conclusion:

Matthew David Wessel's journey as an inventor showcases a relentless pursuit of scientific excellence and a steadfast commitment to pushing the boundaries of pharmaceutical innovation. His latest patents stand as a testament to his ingenuity and unwavering dedication to making a positive impact on the healthcare landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…